New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis

Current Medical Research and Opinion
Dietrich RothenbacherHugh Tilson

Abstract

The assessment and demonstration of a positive benefit-risk balance of a drug is a life-long process and includes specific data from preclinical, clinical development and post-launch experience. However, new integrative approaches are needed to enrich evidence from clinical trials and sponsor-initiated observational studies with information from multiple additional sources, including registry information and other existing observational data and, more recently, health-related administrative claims and medical records databases. To illustrate the value of this approach, this paper exemplifies such a cross-package approach to the area of multiple sclerosis, exploring also possible analytic strategies when using these multiple sources of information.

References

Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·W K Amery, UNKNOWN ISPE
Jan 15, 2005·Pharmacoepidemiology and Drug Safety·John D SeegerAlexander M Walker
Mar 18, 2005·Annual Review of Immunology·Mireia Sospedra, Roland Martin
May 3, 2005·Journal of Clinical Epidemiology·Sebastian Schneeweiss, Jerry Avorn
Jun 17, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Jordi RíoXavier Montalban
Mar 3, 2006·The New England Journal of Medicine·Elliot M FrohmanCedric S Raine
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Robert J GlynnTil Stürmer
Jul 19, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sebastian Schneeweiss, Daniel H Solomon
Feb 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·H ButzkuevenJ P Malkowski
Mar 23, 2007·Journal of the Neurological Sciences·Marinella ClericoLuca Durelli
May 26, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R A MarrieT Vollmer
Sep 18, 2007·Pharmacoepidemiology and Drug Safety·UNKNOWN ISPE
Sep 25, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonC Daniel Mullins
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Samy Suissa, Edeltraut Garbe
Mar 11, 2008·Journal of Biomedical Informatics·Brian C Drolet, Kevin B Johnson
Mar 28, 2009·Journal of Neurology·Peter Flachenecker, Kristin Stuke
Apr 8, 2009·Journal of Clinical Epidemiology·Kevin E ThorpeKalipso Chalkidou
Oct 5, 2010·Journal of Medical Economics·Benjamin J ChastekMaria V Lopez-Bresnahan
Mar 23, 2011·The Mount Sinai Journal of Medicine, New York·Joy Derwenskus
Jun 28, 2011·Pharmacoepidemiology and Drug Safety·Francisca González-RubioAlexandra Prados-Torres
Jul 2, 2011·Nature Reviews. Drug Discovery·Hans-Georg EichlerBrigitte Bloechl-Daum
Sep 8, 2011·Statistics in Medicine·Eloise E Kaizar
Oct 22, 2011·Lancet Neurology·Joep KillesteinChris H Polman
Jan 25, 2012·Pharmacoepidemiology and Drug Safety·Ronald A HermanRyan Carnahan
Jun 20, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Inger BoströmAnne-Marie Landtblom
Jan 12, 2013·Acta Neurologica Scandinavica. Supplementum·M PugliattiUNKNOWN EUReMS Consortium
Jan 4, 2013·Acta Neurologica Scandinavica. Supplementum·S Magalhaes, C Wolfson
Sep 3, 2013·The New England Journal of Medicine·Ole FröbertUNKNOWN TASTE Trial
Sep 3, 2013·The New England Journal of Medicine·Michael S Lauer, Ralph B D'Agostino
Oct 24, 2013·Journal of the American Medical Informatics Association : JAMIA·Mary F DavisJonathan L Haines
Nov 16, 2013·Nature Reviews. Drug Discovery·Hans-Georg EichlerGuido Rasi
Jun 5, 2014·The New England Journal of Medicine·Sebastian Schneeweiss

❮ Previous
Next ❯

Citations

Jan 29, 2016·Drug Discovery Today·Nick HirdHiroaki Kitano
Dec 29, 2016·Current Medical Research and Opinion·Thomas R EinarsonMárcio Machado
Feb 13, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C ZeccaA Czaplinski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved